Review



biotinylated horseradish peroxidase macromolecular complex abc  (Vector Laboratories)


Bioz Verified Symbol Vector Laboratories is a verified supplier
Bioz Manufacturer Symbol Vector Laboratories manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Vector Laboratories biotinylated horseradish peroxidase macromolecular complex abc
    Biotinylated Horseradish Peroxidase Macromolecular Complex Abc, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 17556 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+cripto+biotinylated+ab/VECTASTAIN+ABC+HRP+Kit+(Peroxidase%2C+Standard)/pmc07424341-52-32-41
    Average 96 stars, based on 17556 article reviews
    biotinylated horseradish peroxidase macromolecular complex abc - by Bioz Stars, 2026-11
    96/100 stars

    Images

    Related Articles

    Polymer:

    Article Title: Expression of Desmocollin-1 in carotid atherosclerotic plaques and calcific aortic valves.
    Article Snippet: .. Secondary antibody Mouse/Rabbit IgG VisUCyte HRP Polymer (R&D, # VC002-025) were applied followed by Vectastain ABC complex (Vector Laboratories, Burlingame, California, USA) according to manufacturer protocol. .. Immunostaining was visualized by 1×DAB/H2O2 solution, subsequently counterstained with hematoxylin, and mounted with Permount (Sigma–Aldrich).

    Incubation:

    Article Title: A Bioactive 3D-Bioprinted AuNC@DHLA/GelMA Hydrogel Containing Skin Cells Promotes Burn Wound Healing and Tissue Regeneration.
    Article Snippet: .. Following PBS washes, sections were incubated with biotinylated secondary antibodies for 1 h, and signal amplification was achieved using a VECTASTAIN ABC kit (Vector Laboratories, Burlingame, CA, USA). ..

    Article Title: Intricate mesoscale organization of the anterior commissure in the rhesus monkey, with implications for neuroimaging.
    Article Snippet: .. In brief, this involved incubation overnight at room temperature in primary antibody (1:500, mouse antibody; ImmunoStar, Hudson, WI), followed by 1 h incubation at room temperature in 0.44% biotinylated anti-mouse horse-made IgG (Vector Laboratories, Burlingame, CA), and re-incubation (1 h at room temperature) in 0.8% peroxidase-labeled avidin biotin complex (ABC Standard kit, Vector). .. The bound peroxidase was revealed by incubating the section for 3 min at room temperature, in 0.05% solution of DAB (Sigma, St. Louis, MO) to which 0.005% hydrogen peroxide was added.

    Article Title: Administration of a phosphodiesterase 4B inhibitor reduces hippocampal neuronal cell death after global cerebral ischemia
    Article Snippet: Brain slices were incubated with an anti-mouse IgG antibody diluted (1:250; Burlingame, Vector, CA, USA, Cat No. BA-2000) or NeuN antibody (1:500; Millipore, Billerica, MA, USA, Cat No. MAB377) at room temperature for 2 h. Following incubation, the brain slices were washed with 0.01 M PBS to remove unbound or nonspecifically bound antibodies. .. The brain slices were then incubated with an ABC mixture (Vector Laboratories, Burlingame, CA, USA, Cat. No. PK-4000) at room temperature for 2 h. Immunoreactivity was visualized using 0.06% 3,3′-diaminobenzidine (DAB) in 0.01 M PBS, which forms a brown precipitate in the presence of peroxidase, indicating IgG immunoreactivity. ..

    Amplification:

    Article Title: A Bioactive 3D-Bioprinted AuNC@DHLA/GelMA Hydrogel Containing Skin Cells Promotes Burn Wound Healing and Tissue Regeneration.
    Article Snippet: .. Following PBS washes, sections were incubated with biotinylated secondary antibodies for 1 h, and signal amplification was achieved using a VECTASTAIN ABC kit (Vector Laboratories, Burlingame, CA, USA). ..

    Avidin-Biotin Assay:

    Article Title: Intricate mesoscale organization of the anterior commissure in the rhesus monkey, with implications for neuroimaging.
    Article Snippet: .. In brief, this involved incubation overnight at room temperature in primary antibody (1:500, mouse antibody; ImmunoStar, Hudson, WI), followed by 1 h incubation at room temperature in 0.44% biotinylated anti-mouse horse-made IgG (Vector Laboratories, Burlingame, CA), and re-incubation (1 h at room temperature) in 0.8% peroxidase-labeled avidin biotin complex (ABC Standard kit, Vector). .. The bound peroxidase was revealed by incubating the section for 3 min at room temperature, in 0.05% solution of DAB (Sigma, St. Louis, MO) to which 0.005% hydrogen peroxide was added.

    Activity Assay:

    Article Title: Pathogenic Properties of Human Endometriotic Epithelial Cells Require Steroid Receptor Coactivator-2.
    Article Snippet: For mouse tissues, the M.O.M (Mouse on Mouse) Immunodetection kit 166 ((#BMK-2202) Vector Laboratories, Inc.) was used for S100A10 immunodetection. .. As 167 required, peroxidase activity was visualized using the Vectastain Elite ABC-horse radish 168 peroxidase (HRP) kit (#PK-4000; Vector Laboratories Inc.). ..



    Similar Products

    90
    R&D Systems mouse cripto biotinylated ab
    <t>CRIPTO</t> (CR-1) is dynamically expressed in stem cell-enriched cultures of adenocarcinoma (AC) and squamous cell carcinoma (SCC). (A) Hematoxylin/Eosin staining of paraffin-embedded xenograft sections obtained from two SCC and two AC spheroid cultures (upper panels) and of the parental patient tumor (lower panels), 20X magnification, scale bar 50 μm. Pictures in the upper panels are representative of xenograft sections derived from three different mice. (B) Flow cytometry analysis of surface CRIPTO expression on two SCC and two AC spheroid cultures derived from patients represented in (A) and in . (C) Immunofluorescence staining for CRIPTO in combination with E-Cadherin or Prolyl 4-Hydroxylase subunit beta (P4HB) to show respectively plasmamembrane and endoplasmic reticulum localization on AC1 cells, 60X magnification, 1.8X zoom, scale bar 10 μm. (D) Values obtained from flow cytometry analysis of surface CRIPTO (indicated as percentage of positive cells) in AC1 (light purple rhombus) and SCC1 (light blue square) at the indicated days. The histogram represents the percentage of FACS-positive cells for 7-amino actinomycin D (7-AAD). FACS plots are shown in <xref ref-type=Supplemental Figure 1 . " width="250" height="auto" />
    Mouse Cripto Biotinylated Ab, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+cripto+biotinylated+ab/Mouse+Cripto+Biotinylated+Antibody/pmc09200964-165-8-12
    Average 90 stars, based on 1 article reviews
    mouse cripto biotinylated ab - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results


    CRIPTO (CR-1) is dynamically expressed in stem cell-enriched cultures of adenocarcinoma (AC) and squamous cell carcinoma (SCC). (A) Hematoxylin/Eosin staining of paraffin-embedded xenograft sections obtained from two SCC and two AC spheroid cultures (upper panels) and of the parental patient tumor (lower panels), 20X magnification, scale bar 50 μm. Pictures in the upper panels are representative of xenograft sections derived from three different mice. (B) Flow cytometry analysis of surface CRIPTO expression on two SCC and two AC spheroid cultures derived from patients represented in (A) and in . (C) Immunofluorescence staining for CRIPTO in combination with E-Cadherin or Prolyl 4-Hydroxylase subunit beta (P4HB) to show respectively plasmamembrane and endoplasmic reticulum localization on AC1 cells, 60X magnification, 1.8X zoom, scale bar 10 μm. (D) Values obtained from flow cytometry analysis of surface CRIPTO (indicated as percentage of positive cells) in AC1 (light purple rhombus) and SCC1 (light blue square) at the indicated days. The histogram represents the percentage of FACS-positive cells for 7-amino actinomycin D (7-AAD). FACS plots are shown in <xref ref-type=Supplemental Figure 1 . " width="100%" height="100%">

    Journal: Frontiers in Oncology

    Article Title: CRIPTO Is a Marker of Chemotherapy-Induced Stem Cell Expansion in Non-Small Cell Lung Cancer

    doi: 10.3389/fonc.2022.830873

    Figure Lengend Snippet: CRIPTO (CR-1) is dynamically expressed in stem cell-enriched cultures of adenocarcinoma (AC) and squamous cell carcinoma (SCC). (A) Hematoxylin/Eosin staining of paraffin-embedded xenograft sections obtained from two SCC and two AC spheroid cultures (upper panels) and of the parental patient tumor (lower panels), 20X magnification, scale bar 50 μm. Pictures in the upper panels are representative of xenograft sections derived from three different mice. (B) Flow cytometry analysis of surface CRIPTO expression on two SCC and two AC spheroid cultures derived from patients represented in (A) and in . (C) Immunofluorescence staining for CRIPTO in combination with E-Cadherin or Prolyl 4-Hydroxylase subunit beta (P4HB) to show respectively plasmamembrane and endoplasmic reticulum localization on AC1 cells, 60X magnification, 1.8X zoom, scale bar 10 μm. (D) Values obtained from flow cytometry analysis of surface CRIPTO (indicated as percentage of positive cells) in AC1 (light purple rhombus) and SCC1 (light blue square) at the indicated days. The histogram represents the percentage of FACS-positive cells for 7-amino actinomycin D (7-AAD). FACS plots are shown in Supplemental Figure 1 .

    Article Snippet: Sheep anti-mouse CRIPTO Ab (R&D System, #AF1538) and mouse CRIPTO biotinylated Ab (R&D System, #BAF 1538) were used for coating and detection, respectively.

    Techniques: Staining, Derivative Assay, Flow Cytometry, Expressing, Immunofluorescence

    CRIPTO (CR-1) expression regulates cells proliferation and stem cell gene expression in NSCLC spheroids. (A) Immunoblot analysis of CRIPTO and βActin in SCC1 spheroids transduced with the empty vector (Vector), with CRIPTO shRNA vector (CRIPTO KO) or with exogenous CRIPTO (CRIPTO-over). (B) CRIPTO and stem cell genes (OCT3/4, SOX2, NANOG) mRNA expression in SCC1 transduced with vector, CRIPTO KO or CRIPTO-over sequences. (C) ATP assay performed on SCC1 transduced with the vector, CRIPTO KO or CRIPTO-over sequences, performed 4 days after transduction (D) . Cell cycle analysis of SCC1 transduced as above, performed 3 days after transduction. (E) Soft agar pictures (left; two technical replicates for each sample) and graph (right) of colony forming assay performed on control (Vector), CRIPTO KO and CRIPTO overexpressing SCC1 spheroids. The results are evaluated as colony formation in semisolid culture and expressed as normalized colony size/percentage over plated cells. (F) ELISA assay performed on SCC1 cells transduced with empty vector, CRIPTO KO sequences and CRIPTO overexpression vector. (G) Invasion/migration assay performed on vector-transduced, CRIPTO KO and CRIPTO overexpressing SCC1 cells. *P < 0.05; **P < 0.01, ***P < 0.001 by unpaired student’s t test (transduced vs vector).

    Journal: Frontiers in Oncology

    Article Title: CRIPTO Is a Marker of Chemotherapy-Induced Stem Cell Expansion in Non-Small Cell Lung Cancer

    doi: 10.3389/fonc.2022.830873

    Figure Lengend Snippet: CRIPTO (CR-1) expression regulates cells proliferation and stem cell gene expression in NSCLC spheroids. (A) Immunoblot analysis of CRIPTO and βActin in SCC1 spheroids transduced with the empty vector (Vector), with CRIPTO shRNA vector (CRIPTO KO) or with exogenous CRIPTO (CRIPTO-over). (B) CRIPTO and stem cell genes (OCT3/4, SOX2, NANOG) mRNA expression in SCC1 transduced with vector, CRIPTO KO or CRIPTO-over sequences. (C) ATP assay performed on SCC1 transduced with the vector, CRIPTO KO or CRIPTO-over sequences, performed 4 days after transduction (D) . Cell cycle analysis of SCC1 transduced as above, performed 3 days after transduction. (E) Soft agar pictures (left; two technical replicates for each sample) and graph (right) of colony forming assay performed on control (Vector), CRIPTO KO and CRIPTO overexpressing SCC1 spheroids. The results are evaluated as colony formation in semisolid culture and expressed as normalized colony size/percentage over plated cells. (F) ELISA assay performed on SCC1 cells transduced with empty vector, CRIPTO KO sequences and CRIPTO overexpression vector. (G) Invasion/migration assay performed on vector-transduced, CRIPTO KO and CRIPTO overexpressing SCC1 cells. *P < 0.05; **P < 0.01, ***P < 0.001 by unpaired student’s t test (transduced vs vector).

    Article Snippet: Sheep anti-mouse CRIPTO Ab (R&D System, #AF1538) and mouse CRIPTO biotinylated Ab (R&D System, #BAF 1538) were used for coating and detection, respectively.

    Techniques: Expressing, Gene Expression, Western Blot, Transduction, Plasmid Preparation, shRNA, ATP Assay, Cell Cycle Assay, Control, Enzyme-linked Immunosorbent Assay, Over Expression, Migration

    NSCLC subpopulations expressing high or low CRIPTO (CR-1) levels are interconvertible in vitro and in vivo . (A) FACS-based separation of CRIPTO high and CRIPTO low subpopulations of AC1 spheroid cultures. (B) Self-renewal capacity of sorted CRIPTO high and CRIPTO low AC1 spheroid cells, evaluated as colony formation in semisolid culture and expressed in bottom panels as normalized colony size/percentage over plated cells. (C) qRT-PCR analysis of CRIPTO and stem cell related genes (OCT3/4, SOX2, NANOG) performed on CRIPTO high and CRIPTO low subpopulations of AC1 spheroids. (D) Proliferation curve of CRIPTO high (dark pink square) and CRIPTO low (light blue dot) subpopulations or Bulk (burgundy triangle) cultures of AC1 spheroids, starting at day 0 (after sorting) and monitored at the indicated times. (E) qRT-PCR analysis of CRIPTO high (light purple histogram) and CRIPTO low (light blue histogram) subpopulations at the indicated times starting at day 0 after sorting. (F) Left: In vivo growth of tumor xenografts obtained by subcutaneous inoculation of CRIPTO high (dark pink square) and CRIPTO low (light blue dot) subpopulations or Bulk (burgundy triangle) cultures of AC1 spheroids, monitored at the indicated times. Results shown are the mean ± SEM of values obtained using 4 mice per group. *P < 0.05; **P < 0.01, ***P < 0.001. Middle: representative confocal images of CRIPTO (red) staining of CRIPTO high , CRIPTO low and Bulk tumors. 40X magnification, scale bar 50 μm. Right: quantification of CRIPTO performed on 3 sets composed of 5 fields/group. **P < 0.01. AU, arbitrary units.

    Journal: Frontiers in Oncology

    Article Title: CRIPTO Is a Marker of Chemotherapy-Induced Stem Cell Expansion in Non-Small Cell Lung Cancer

    doi: 10.3389/fonc.2022.830873

    Figure Lengend Snippet: NSCLC subpopulations expressing high or low CRIPTO (CR-1) levels are interconvertible in vitro and in vivo . (A) FACS-based separation of CRIPTO high and CRIPTO low subpopulations of AC1 spheroid cultures. (B) Self-renewal capacity of sorted CRIPTO high and CRIPTO low AC1 spheroid cells, evaluated as colony formation in semisolid culture and expressed in bottom panels as normalized colony size/percentage over plated cells. (C) qRT-PCR analysis of CRIPTO and stem cell related genes (OCT3/4, SOX2, NANOG) performed on CRIPTO high and CRIPTO low subpopulations of AC1 spheroids. (D) Proliferation curve of CRIPTO high (dark pink square) and CRIPTO low (light blue dot) subpopulations or Bulk (burgundy triangle) cultures of AC1 spheroids, starting at day 0 (after sorting) and monitored at the indicated times. (E) qRT-PCR analysis of CRIPTO high (light purple histogram) and CRIPTO low (light blue histogram) subpopulations at the indicated times starting at day 0 after sorting. (F) Left: In vivo growth of tumor xenografts obtained by subcutaneous inoculation of CRIPTO high (dark pink square) and CRIPTO low (light blue dot) subpopulations or Bulk (burgundy triangle) cultures of AC1 spheroids, monitored at the indicated times. Results shown are the mean ± SEM of values obtained using 4 mice per group. *P < 0.05; **P < 0.01, ***P < 0.001. Middle: representative confocal images of CRIPTO (red) staining of CRIPTO high , CRIPTO low and Bulk tumors. 40X magnification, scale bar 50 μm. Right: quantification of CRIPTO performed on 3 sets composed of 5 fields/group. **P < 0.01. AU, arbitrary units.

    Article Snippet: Sheep anti-mouse CRIPTO Ab (R&D System, #AF1538) and mouse CRIPTO biotinylated Ab (R&D System, #BAF 1538) were used for coating and detection, respectively.

    Techniques: Expressing, In Vitro, In Vivo, Quantitative RT-PCR, Staining

    Chemotherapy treatment increases CRIPTO (CR-1) expression and tumor progression in NSCLC xenografts. (A) Flow cytometry analysis of CRIPTO on SCC1 cells treated with vehicle only (Vehicle) or with chemotherapeutic agents (Cis+Gem early and Cis+Gem late). Cells in the Cis+Gem samples were treated with Cisplatin 5 μM plus Gemcitabine 25 μM for 4 days then washed, replated and analyzed after 3 additional days (Cis+Gem early) or 7 additional days (Cis+Gem late). The graph shows the mean ± SD of two independent experiments. Ns, non-significant, ***P < 0.001. (B) Left: Xenograft volume of SCC1 spheroids cells treated with Vehicle (Vehicle, light blue square) or with Cisplatin plus Gemcitabine (Cis+Gem, Dark pink dots). Mean ± SEM, 6 mice/group. **P < 0.01 (two-tailed t test). Middle: representative confocal images of CRIPTO (red) and TUNEL (green) staining of Vehicle and Cis+Gem treated tumors. 40X magnification, scale bar 50 μm. Right: quantification of CRIPTO and TUNEL performed on 3 sets composed of 5 fields/group. **P < 0.01. AU, arbitrary units. (C) Tumor variation after treatment withdrawal of SCC1 spheroids treated with vehicle (Vehicle, light blue square), and Cis plus Gemcitabine (Cis+Gem, dark pink dots). Mean ± SEM, 4 mice/group. (D) qRT-PCR analysis of CRIPTO and Cyclin E mRNA expression of SCC1-derived xenografts, monitored during treatment and after treatment withdrawal at the indicated times. *P < 0.05; **P < 0.01, ***P < 0.001.

    Journal: Frontiers in Oncology

    Article Title: CRIPTO Is a Marker of Chemotherapy-Induced Stem Cell Expansion in Non-Small Cell Lung Cancer

    doi: 10.3389/fonc.2022.830873

    Figure Lengend Snippet: Chemotherapy treatment increases CRIPTO (CR-1) expression and tumor progression in NSCLC xenografts. (A) Flow cytometry analysis of CRIPTO on SCC1 cells treated with vehicle only (Vehicle) or with chemotherapeutic agents (Cis+Gem early and Cis+Gem late). Cells in the Cis+Gem samples were treated with Cisplatin 5 μM plus Gemcitabine 25 μM for 4 days then washed, replated and analyzed after 3 additional days (Cis+Gem early) or 7 additional days (Cis+Gem late). The graph shows the mean ± SD of two independent experiments. Ns, non-significant, ***P < 0.001. (B) Left: Xenograft volume of SCC1 spheroids cells treated with Vehicle (Vehicle, light blue square) or with Cisplatin plus Gemcitabine (Cis+Gem, Dark pink dots). Mean ± SEM, 6 mice/group. **P < 0.01 (two-tailed t test). Middle: representative confocal images of CRIPTO (red) and TUNEL (green) staining of Vehicle and Cis+Gem treated tumors. 40X magnification, scale bar 50 μm. Right: quantification of CRIPTO and TUNEL performed on 3 sets composed of 5 fields/group. **P < 0.01. AU, arbitrary units. (C) Tumor variation after treatment withdrawal of SCC1 spheroids treated with vehicle (Vehicle, light blue square), and Cis plus Gemcitabine (Cis+Gem, dark pink dots). Mean ± SEM, 4 mice/group. (D) qRT-PCR analysis of CRIPTO and Cyclin E mRNA expression of SCC1-derived xenografts, monitored during treatment and after treatment withdrawal at the indicated times. *P < 0.05; **P < 0.01, ***P < 0.001.

    Article Snippet: Sheep anti-mouse CRIPTO Ab (R&D System, #AF1538) and mouse CRIPTO biotinylated Ab (R&D System, #BAF 1538) were used for coating and detection, respectively.

    Techniques: Expressing, Flow Cytometry, Two Tailed Test, TUNEL Assay, Staining, Quantitative RT-PCR, Derivative Assay